MARKER THERAPEUTICS, INC. (MRKR) Total liabilities 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) total liabilities at each fiscal year-end, per SEC filings.
$2.3MFY2025 · since FY2017: $1.5M → $2.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.3M | -34.4% |
| FY2024 | $3.5M | +12.7% |
| FY2023 | $3.1M | -79.3% |
| FY2022 | $14.8M | -38.6% |
| FY2021 | $24.1M | +32.2% |
| FY2020 | $18.3M | +703.8% |
| FY2019 | $2.3M | -18.9% |
| FY2018 | $2.8M | +84.2% |
| FY2017 | $1.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Net marginMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Shareholders’ equityMRKR overview →